You know Dr. J. Craig Venter as the pioneer of genome sequencing, and now he's forging new territory yet again to merge life science with computer science to extend humans' healthy lifespan and redefine the way we age. Moderated by I-han Chou, Senior Strategy Editor at Nature.

David Ebersman left his post as CFO of Facebook (before that he was CFO of Genentech) to focus on bringing technology to healthcare in an effort to make experiences that affect us all less isolating and frustrating. We'll explore why he made the leap, how his current ventures compare to building other iconic and disruptive companies, and what his vision is for the future of digital health.

An early-stage company with the potential and followthrough to become a billion dollar paradigm-shifter can be as elusive, but hopefully not as mythical, as a unicorn. We pick the brains of investing heavy-weights to talk cold, hard facts: where can we find unicorns in digital health?

Virtual reality has transformed the way we think of and create new worlds, but it also allows us to explore the inner-most workings of the human body. We'll discuss the very real implications virtual reality is having on healthcare—from how we study biological structures to how we administer care.

As the Founder and Managing Partner of Social+Capital Partnership, Chamath Palihapitiya is the "it" man of socially responsible investing. Hear his take on what needs to change in healthcare and how his investment thesis focuses on companies that are drastically doing just that. Moderated by Jessica Lessin, Founder and Editor-in-Chief of The Information.

Rock Health portfolio company co-founders, Thomas Goetz at Iodine, Sandy Jen of Honor, Thea Runyan of Kurbo Health, and Alejandro Foung of Lantern share their experiences about leveraging thousands of allied healthcare workers to deliver better healthcare.